Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
Background: Nitric oxide (NO) has been associated with insulin resistance and type 2 diabetes (T2D). NO is synthesized enzymatically from l-arginine (l-Arg) by three NO synthase (NOS) isoforms, Neuronal NOS (nNOS or NOS1), Inducible NOS (iNOS or NOS2), and Endothelial NOS (eNOS or NOS3). The impact...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2018-11-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/15163 |
id |
doaj-4acc6c28c5004e4f95904fc499d70587 |
---|---|
record_format |
Article |
spelling |
doaj-4acc6c28c5004e4f95904fc499d705872021-01-02T15:45:08ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852251-60932018-11-014711Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern IranYasaman GARME0Mahdiyeh MOUDI1Ramin SARAVANI2Hamidreza GALAVI3Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IranCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IranCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran AND Dept. of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IranCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran AND Dept. of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran Background: Nitric oxide (NO) has been associated with insulin resistance and type 2 diabetes (T2D). NO is synthesized enzymatically from l-arginine (l-Arg) by three NO synthase (NOS) isoforms, Neuronal NOS (nNOS or NOS1), Inducible NOS (iNOS or NOS2), and Endothelial NOS (eNOS or NOS3). The impact of NOS2 gene polymorphism was investigated on the susceptibility of T2D in a sample of Iranian population (Southeastern of Iran). Methods: In 2015, the present case-control study was conducted on 152 T2D patients and 157 healthy control subjects (HCs) referring to Bu-ali Hospital of Zahedan, eastern Iran. Genotyping of NOS2 rs2779248T/C and rs1137933C/T variants were done using the Tetra-Amplification Refractory Mutation System Polymerase Chain Reaction (Tetra-ARMS PCR) method. Results: CT genotype of rs1137933C/T was significantly associated with increased risk of T2D (P<0.0001). The T allele of this single nucleotide polymorphism (SNP) was also strongly associated with T2D risk (P<0.0001). For rs2779248 T/C, TC genotype of this SNP decreased the risk of T2D (OR=0.25 95%CI= 0.15-0.42, P<0.0001); however, CC genotype of this SNP increased the risk of T2D (P<0.005). There was no significant association between clinical-demographic characteristics of T2D group with respect to both SNPS in dominant. Conclusion: CT genotype and C allele of NOS2 rs1137933 C/T polymorphism were associated with a higher risk of T2D, and no association was observed between T allele of NOS2 rs2779248 T/C polymorphism and T2D while TC genotype of this SNP decreased the risk of T2D in the study participants. https://ijph.tums.ac.ir/index.php/ijph/article/view/15163Type 2 diabetes mellitusSingle nucleotide polymorphismNitric oxide synthase type IIInducible nitric oxide synthase |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yasaman GARME Mahdiyeh MOUDI Ramin SARAVANI Hamidreza GALAVI |
spellingShingle |
Yasaman GARME Mahdiyeh MOUDI Ramin SARAVANI Hamidreza GALAVI Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran Iranian Journal of Public Health Type 2 diabetes mellitus Single nucleotide polymorphism Nitric oxide synthase type II Inducible nitric oxide synthase |
author_facet |
Yasaman GARME Mahdiyeh MOUDI Ramin SARAVANI Hamidreza GALAVI |
author_sort |
Yasaman GARME |
title |
Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran |
title_short |
Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran |
title_full |
Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran |
title_fullStr |
Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran |
title_full_unstemmed |
Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran |
title_sort |
nitric oxide synthase 2 polymorphisms (rs2779248t/c and rs1137933c/t) and the risk of type 2 diabetes in zahedan, southeastern iran |
publisher |
Tehran University of Medical Sciences |
series |
Iranian Journal of Public Health |
issn |
2251-6085 2251-6093 |
publishDate |
2018-11-01 |
description |
Background: Nitric oxide (NO) has been associated with insulin resistance and type 2 diabetes (T2D). NO is synthesized enzymatically from l-arginine (l-Arg) by three NO synthase (NOS) isoforms, Neuronal NOS (nNOS or NOS1), Inducible NOS (iNOS or NOS2), and Endothelial NOS (eNOS or NOS3). The impact of NOS2 gene polymorphism was investigated on the susceptibility of T2D in a sample of Iranian population (Southeastern of Iran).
Methods: In 2015, the present case-control study was conducted on 152 T2D patients and 157 healthy control subjects (HCs) referring to Bu-ali Hospital of Zahedan, eastern Iran. Genotyping of NOS2 rs2779248T/C and rs1137933C/T variants were done using the Tetra-Amplification Refractory Mutation System Polymerase Chain Reaction (Tetra-ARMS PCR) method.
Results: CT genotype of rs1137933C/T was significantly associated with increased risk of T2D (P<0.0001). The T allele of this single nucleotide polymorphism (SNP) was also strongly associated with T2D risk (P<0.0001). For rs2779248 T/C, TC genotype of this SNP decreased the risk of T2D (OR=0.25 95%CI= 0.15-0.42, P<0.0001); however, CC genotype of this SNP increased the risk of T2D (P<0.005). There was no significant association between clinical-demographic characteristics of T2D group with respect to both SNPS in dominant.
Conclusion: CT genotype and C allele of NOS2 rs1137933 C/T polymorphism were associated with a higher risk of T2D, and no association was observed between T allele of NOS2 rs2779248 T/C polymorphism and T2D while TC genotype of this SNP decreased the risk of T2D in the study participants.
|
topic |
Type 2 diabetes mellitus Single nucleotide polymorphism Nitric oxide synthase type II Inducible nitric oxide synthase |
url |
https://ijph.tums.ac.ir/index.php/ijph/article/view/15163 |
work_keys_str_mv |
AT yasamangarme nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran AT mahdiyehmoudi nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran AT raminsaravani nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran AT hamidrezagalavi nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran |
_version_ |
1724352480120143872 |